Medication Management
Thomas Reinke

Mike Pellini, MD

With limited peer-reviewed literature, health plans take an evaluative approach to tumor profile testing

Legislation & Regulation
John Carroll

At issue is how much large provider systems can charge for services after they’ve acquired physician practices

Robert Royce, PhD

Robert Royce, PhD

The country’s catastrophic economic situation shrinks coverage, closes hospitals, and cuts physicians’ salaries — and that might be just the beginning

Plan Watch
Frank Diamond

The insurer hopes to give businesses of between 50 and 400 employees more flexibility under defined contribution

Tomorrow’s Medicine
Thomas Morrow, MD

This new treatment for nephritic cystinosis costs a quarter million annually, whereas the original formulation comes in at $8,000

News & Commentary
Frank Diamond

A blueprint for high-volume, high-quality lung cancer screening that is detecting cancer earlier—and helping to save lives

Clinical Brief

Multiple Sclerosis: New Perspectives on the Patient Journey–2019 Update
Summary of an Actuarial Analysis and Report